Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of inhibitors targeting specific enzymes involved in disease pathways. Its structure supports activity in medicinal chemistry, especially in the design of drugs requiring enhanced metabolic stability and bioavailability. Commonly applied in research settings for creating analogs in oncology and inflammation-related drug discovery. The trifluoromethyl and hydroxyimidoyl groups contribute to binding affinity and selectivity in target molecules.